The purpose of this legislation, known as the "Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026," is to improve access to affordable medications for seniors enrolled in Medicare's prescription drug plans. It aims to ensure that certain generic drugs and biosimilar biological products are included in the drug formularies of these plans, making them more accessible and cost-effective for beneficiaries.